A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

Sponsor
Winston Laboratories (Industry)
Overall Status
Completed
CT.gov ID
NCT00033839
Collaborator
(none)
60
26
17.9
2.3
0.1

Study Details

Study Description

Brief Summary

This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).

Condition or Disease Intervention/Treatment Phase
  • Drug: Civamide (Zucapsaicin)
Phase 3

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache
Study Start Date :
Jan 1, 2002
Actual Primary Completion Date :
Jul 1, 2003
Actual Study Completion Date :
Jul 1, 2003

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    • At least 2 year history of episodic cluster headache (meeting IHS criteria)

    • At least 2 previous episodes

    • Expected duration of cluster period is at least 6 weeks but not longer than 16 weeks

    • At least 1 but not more than 8 headaches on each of the 3 days immediately prior to treatment

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Valley Neurological Headache & Research Center Phoenix Arizona United States 85020
    2 Neurological Associates of Tucson Tucson Arizona United States 85712
    3 Northern California Headache Clinic Mountain View California United States 94040
    4 San Francisco Clinical Research Center San Francisco California United States 94109
    5 California Medical Clinic for Headache Santa Monica California United States 90404
    6 New England Center for Headache, PC Stamford Connecticut United States 06902
    7 Neurology Clinical Research, Inc. Plantation Florida United States 33324
    8 Neurology and Headache Specialists of Atlanta Decatur Georgia United States 30033
    9 Diamond Headache Clinic Chicago Illinois United States 60614
    10 Boston Clinical Research Center Wellesley Hills Massachusetts United States 02481
    11 Michigan Headache Pain & Neurological Institute Ann Arbor Michigan United States 48104
    12 Henry Ford Hospital Department of Neurology Detroit Michigan United States 48202
    13 Department of Neurology Mayo Clinic Rochester Minnesota United States 55905
    14 Mercy Health Research Chesterfield Missouri United States 63017
    15 Headache Care Center/Clinvest Springfield Missouri United States 65804
    16 Dartmouth Hitchcock Medical Center Lebanon New Hampshire United States 03756
    17 New York Headache Center New York New York United States 10021
    18 The Headache Wellness Center Greensboro North Carolina United States 27401
    19 Cincinnati Headache Clinic Cincinnati Ohio United States 45219
    20 Cleveland Clinic Foundation Cleveland Ohio United States 44195
    21 University of Oklahoma Oklahoma City Oklahoma United States 73104
    22 Neurological Associates of Tulsa, Inc. Tulsa Oklahoma United States 74136
    23 Jefferson Headache Center Philadelphia Pennsylvania United States 19107
    24 Nashville Neuroscience Center Nashville Tennessee United States 37203
    25 Houston Headache Clinic Houston Texas United States 77004
    26 The Neurology and Headache Treatment Center (Innovative Clinical Research) Alexandria Virginia United States 22304

    Sponsors and Collaborators

    • Winston Laboratories

    Investigators

    • Study Director: Scott B. Phillips, M.D., Winston Laboratories

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00033839
    Other Study ID Numbers:
    • WL-1001-02-02
    First Posted:
    Apr 12, 2002
    Last Update Posted:
    Jun 10, 2011
    Last Verified:
    Jun 1, 2011
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 10, 2011